Iodide

Iodide

SCHEMBL1758472

CCCC[n+]1ccn(CCC)c1.[I-]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
HSP90AA1 P07900 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
APAF1 O14727 1/20 0.44
NPC1 O15118 1/20 0.44
PLA2G1B P04054 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
FDPS P14324 11/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL899120 0.98 MEN1 (0.49) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Hydrochloric Acid SCHEMBL960558 0.96 MEN1 (0.47) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bromide SCHEMBL3800998 0.96 MEN1 (0.51) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL413901 0.93 SMN1; SMN2 (0.53) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL11536415 0.93 SMN1; SMN2 (0.53) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL17273606 0.92 MEN1 (0.51) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL961671 0.92 MEN1 (0.51) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL2533632 0.92 SMN1; SMN2 (0.47) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL28349886 0.91 MEN1 (0.44) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
SCHEMBL28358357 0.91 MEN1 (0.44) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2790197-A2 Electrolyte for dye sensitized solar cell and dye sensitized solar cell using the same Samsung SDI Co., Ltd. (KR) 2014-10-15 EP claimed
US-20140299190-A1 ELECTROLYTE FOR DYE SENSITIZED SOLAR CELL AND DYE SENSITIZED SOLAR CELL USING THE SAME SAMSUNG SDI CO., LTD. (KR) 2014-10-09 US claimed
US-20110100461-A1 ELECTROLYTE COMPOSITION AND DYE-SENSITIZED SOLAR CELL HAVING THE SAME EVERLIGHT USA, INC. (US) 2011-05-05 US claimed
US-20110100464-A1 Electrolyte composition and dye-sensitized solar cell using the same EVERLIGHT USA, INC. (US) 2011-05-05 US claimed
US-12540715-B2 Lighting diffuser plate for collecting and recycling light energy, and lighting apparatus system comprising same DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2026-02-03 US disclosed
US-20250216053-A1 LIGHTING DIFFUSER PLATE FOR COLLECTING AND RECYCLING LIGHT ENERGY, AND LIGHTING APPARATUS SYSTEM COMPRISING SAME DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2025-07-03 US disclosed
EP-2790197-A2 Electrolyte for dye sensitized solar cell and dye sensitized solar cell using the same Samsung SDI Co., Ltd. (KR) 2014-10-15 EP disclosed
US-20140299190-A1 ELECTROLYTE FOR DYE SENSITIZED SOLAR CELL AND DYE SENSITIZED SOLAR CELL USING THE SAME SAMSUNG SDI CO., LTD. (KR) 2014-10-09 US disclosed
CN-102977321-A compound for solar cell electrolyte, preparation method thereof, electrolyte containing compound and solar cell EVERLIGHT CHEM IND CORP 2013-03-20 CN disclosed
US-20130056075-A1 COMPOUNDS FOR USE IN ELECTROLYTE FOR SOLAR CELL, METHOD FOR PREPARING THE SAME, AND ELECTROLYTE AND SOLAR CELL HAVING THE SAME EVERLIGHT USA, INC. (US) 2013-03-07 US disclosed
CN-102446630-A Electrolyte composition and dye-sensitized solar cell using same ETHICAL INTERNAT TRADING & WAREHOUSING SHANGHAI CO LTD 2012-05-09 CN disclosed
CN-102347138-A Electrolyte composition for dye-sensitized solar cell and solar cell using same EVERLIGHT CHEMICAL IND CO LTD 2012-02-08 CN disclosed
US-20110100461-A1 ELECTROLYTE COMPOSITION AND DYE-SENSITIZED SOLAR CELL HAVING THE SAME EVERLIGHT USA, INC. (US) 2011-05-05 US disclosed
US-20110100464-A1 Electrolyte composition and dye-sensitized solar cell using the same EVERLIGHT USA, INC. (US) 2011-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130056075-A1 COMPOUNDS FOR USE IN ELECTROLYTE FOR SOLAR CELL, METHOD FOR PREPARING THE SAME, AND ELECTROLYTE AND SOLAR CELL HAVING THE SAME HCN2, SCNN1A, HCN1 MEN1 98/4885HSP90AA1 4875/4885KMT2A 1712/4885
US-12540715-B2 Lighting diffuser plate for collecting and recycling light energy, and lighting apparatus system comprising same SOD1, SLC30A7, SLC39A7 MEN1 613/4885HSP90AA1 4260/4885KMT2A 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.